Topics

Gradifi Company Profile

02:36 EST 23rd January 2020 | BioPortfolio

Gradifi is a best-in-class, student loan repayment solution aimed at tackling the nation's $1.4 trillion student loan problem. Gradifi helps employers attract and retain talent by enabling them to make direct contributions to their employees’ student loans and accelerate the pay-off of the debt. Acquired by First Republic Bank (NYSE: FRC) in 2016, Gradifi is a pioneer of the SLP Plan™ (Student Loan Paydown) employee benefit. To learn more, visit www.gradifi.com or twitter.com/gradifi.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Gradifi

Gradifi is a best-in-class, student loan repayment solution aimed at tackling the nation's $1.4 trillion student loan problem. Gradifi helps employers attract and retain talent by...

More Information about "Gradifi" on BioPortfolio

We have published hundreds of Gradifi news stories on BioPortfolio along with dozens of Gradifi Clinical Trials and PubMed Articles about Gradifi for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gradifi Companies in our database. You can also find out about relevant Gradifi Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record